312 related articles for article (PubMed ID: 19218280)
1. Loss of neuronatin expression is associated with promoter hypermethylation in pituitary adenoma.
Revill K; Dudley KJ; Clayton RN; McNicol AM; Farrell WE
Endocr Relat Cancer; 2009 Jun; 16(2):537-48. PubMed ID: 19218280
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide analysis in a murine Dnmt1 knockdown model identifies epigenetically silenced genes in primary human pituitary tumors.
Dudley KJ; Revill K; Whitby P; Clayton RN; Farrell WE
Mol Cancer Res; 2008 Oct; 6(10):1567-74. PubMed ID: 18922972
[TBL] [Abstract][Full Text] [Related]
3. Loss of expression of the growth inhibitory gene GADD45gamma, in human pituitary adenomas, is associated with CpG island methylation.
Bahar A; Bicknell JE; Simpson DJ; Clayton RN; Farrell WE
Oncogene; 2004 Jan; 23(4):936-44. PubMed ID: 14647444
[TBL] [Abstract][Full Text] [Related]
4. Preferential loss of Death Associated Protein kinase expression in invasive pituitary tumours is associated with either CpG island methylation or homozygous deletion.
Simpson DJ; Clayton RN; Farrell WE
Oncogene; 2002 Feb; 21(8):1217-24. PubMed ID: 11850841
[TBL] [Abstract][Full Text] [Related]
5. Frequent epigenetic inactivation of the SLIT2 gene in gliomas.
Dallol A; Krex D; Hesson L; Eng C; Maher ER; Latif F
Oncogene; 2003 Jul; 22(29):4611-6. PubMed ID: 12881718
[TBL] [Abstract][Full Text] [Related]
6. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
7. Expression of neuro D1 in human normal pituitaries and pituitary adenomas.
Oyama K; Sanno N; Teramoto A; Osamura RY
Mod Pathol; 2001 Sep; 14(9):892-9. PubMed ID: 11557786
[TBL] [Abstract][Full Text] [Related]
8. Genetic and functional analysis of neuronatin in mice with maternal or paternal duplication of distal Chr 2.
Kikyo N; Williamson CM; John RM; Barton SC; Beechey CV; Ball ST; Cattanach BM; Surani MA; Peters J
Dev Biol; 1997 Oct; 190(1):66-77. PubMed ID: 9331332
[TBL] [Abstract][Full Text] [Related]
9. Expression of interleukin-6, interleukin-6 receptor (gp80), and the receptor's signal-transducing subunit (gp130) in human normal pituitary glands and pituitary adenomas.
Kurotani R; Yasuda M; Oyama K; Egashira N; Sugaya M; Teramoto A; Osamura RY
Mod Pathol; 2001 Aug; 14(8):791-7. PubMed ID: 11504839
[TBL] [Abstract][Full Text] [Related]
10. Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island.
Simpson DJ; Hibberts NA; McNicol AM; Clayton RN; Farrell WE
Cancer Res; 2000 Mar; 60(5):1211-6. PubMed ID: 10728677
[TBL] [Abstract][Full Text] [Related]
11. The neuronatin gene resides in a "micro-imprinted" domain on human chromosome 20q11.2.
Evans HK; Wylie AA; Murphy SK; Jirtle RL
Genomics; 2001 Sep; 77(1-2):99-104. PubMed ID: 11543638
[TBL] [Abstract][Full Text] [Related]
12. Expression of pituitary homeo box 1 (Ptx1) in human non-neoplastic pituitaries and pituitary adenomas.
Tahara S; Kurotani R; Sanno N; Takumi I; Yoshimura S; Osamura RY; Teramoto A
Mod Pathol; 2000 Oct; 13(10):1097-108. PubMed ID: 11048804
[TBL] [Abstract][Full Text] [Related]
13. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of the p16/CDKN2A/MTSI gene and loss of protein expression is associated with nonfunctional pituitary adenomas but not somatotrophinomas.
Simpson DJ; Bicknell JE; McNicol AM; Clayton RN; Farrell WE
Genes Chromosomes Cancer; 1999 Apr; 24(4):328-36. PubMed ID: 10092131
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation-mediated silencing of neuronatin (NNAT) in pig parthenogenetic fetuses.
Chen X; Wang T; Lv Q; Wang A; Ouyang H; Li Z
Gene; 2014 Nov; 552(1):204-8. PubMed ID: 25240791
[TBL] [Abstract][Full Text] [Related]
16. HESX1 expression in human normal pituitaries and pituitary adenomas.
Mantovani G; Asteria C; Pellegrini C; Bosari S; Alberti L; Bondioni S; Peverelli E; Spada A; Beck-Peccoz P
Mol Cell Endocrinol; 2006 Mar; 247(1-2):135-9. PubMed ID: 16414177
[TBL] [Abstract][Full Text] [Related]
17. Imprinted expression of neuronatin from modified BAC transgenes reveals regulation by distinct and distant enhancers.
John RM; Aparicio SA; Ainscough JF; Arney KL; Khosla S; Hawker K; Hilton KJ; Barton SC; Surani MA
Dev Biol; 2001 Aug; 236(2):387-99. PubMed ID: 11476579
[TBL] [Abstract][Full Text] [Related]
18. Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas.
Kirsch M; Mörz M; Pinzer T; Schackert HK; Schackert G
Genes Chromosomes Cancer; 2009 Feb; 48(2):143-54. PubMed ID: 18973139
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of the imprinted NNAT locus occurs frequently in pediatric acute leukemia.
Kuerbitz SJ; Pahys J; Wilson A; Compitello N; Gray TA
Carcinogenesis; 2002 Apr; 23(4):559-64. PubMed ID: 11960906
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma in the human pituitary gland: expression and splicing pattern in adenomas versus normal pituitary.
Occhi G; Albiger N; Berlucchi S; Gardiman M; Scanarini M; Scienza R; Fassina A; Mantero F; Scaroni C
J Neuroendocrinol; 2007 Jul; 19(7):552-9. PubMed ID: 17561883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
